Lastly, our patient's case is similar to the reported cases of other TNF inhibitors (analogy). Initially, numerous case reports and disease registries highlighted an association between new-onset IBD in patients with AS and JIA treated with TNF inhibitors, with etanercept being more frequently implicated than infliximab or adalimumab [27,29-40]. The gene discussed is TNF; the disease is inflammatory bowel disease.